FY2025 · ended Dec 31, 2025 · Revenue $0, -100.0% YoY · Filed Mar 27, 2026
Adagio Medical Holdings, Inc. (ADGM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $25.1 million. Free cash flow was -$19.4 million. As of Jun 30, 2026 it held $7.7 million in cash and investments and $26.0 million in total debt.
Revenue (TTM)
$-280,000
Net income (TTM)
$-27.14M
Operating cash flow (TTM)
$-16.53M
Free cash flow (TTM)
$-16.57M
EPS (TTM)
$-1.36
Dividend per share
$0.00
Shares outstanding
22.21M
+44.4% vs prior year
Net cash
$-18.26M
as of Jun 30, 2026
Operating margin
7079.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ADGM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Laguna Hills, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2006986
- Former names
- Aja Holdco, Inc. (until Aug 1, 2024)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2023 |
|---|---|---|
| Revenue | $0 | $300,000 |
| Operating income | -$21.9M | -$27.9M |
| Net income | -$25.1M | -$36.6M |
| Diluted EPS | -$1.51 | -$48.16 |
| Operating cash flow | -$19.0M | -$25.7M |
| Free cash flow | -$19.4M | -$26.0M |
| Total assets | $43.3M | — |
| Total liabilities | $30.9M | — |
| Stockholders' equity | $12.4M | — |
| Cash and investments | $17.1M | — |
| Total debt | $21.8M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 5, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 26, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Oct 1, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
All 234 Adagio Medical Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.